These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
657 related items for PubMed ID: 24612139
21. Vernodalol enhances TRAIL-induced apoptosis in diffuse large B-cell lymphoma cells. Wu W, Yang Y, Deng G, Ma L, Wei G, Zheng G, Han X, He D, Zhao Y, He J, Cai Z, Yu R. Mol Carcinog; 2017 Oct; 56(10):2190-2199. PubMed ID: 28467689 [Abstract] [Full Text] [Related]
22. The anti-obesity drug orlistat promotes sensitivity to TRAIL by two different pathways in hormone-refractory prostate cancer cells. Fujiwara J, Sowa Y, Horinaka M, Koyama M, Wakada M, Miki T, Sakai T. Int J Oncol; 2012 May; 40(5):1483-91. PubMed ID: 22328338 [Abstract] [Full Text] [Related]
23. OSMI-1 Enhances TRAIL-Induced Apoptosis through ER Stress and NF-κB Signaling in Colon Cancer Cells. Lee SJ, Lee DE, Choi SY, Kwon OS. Int J Mol Sci; 2021 Oct 14; 22(20):. PubMed ID: 34681736 [Abstract] [Full Text] [Related]
24. Ilimaquinone induces death receptor expression and sensitizes human colon cancer cells to TRAIL-induced apoptosis through activation of ROS-ERK/p38 MAPK-CHOP signaling pathways. Do MT, Na M, Kim HG, Khanal T, Choi JH, Jin SW, Oh SH, Hwang IH, Chung YC, Kim HS, Jeong TC, Jeong HG. Food Chem Toxicol; 2014 Sep 14; 71():51-9. PubMed ID: 24930757 [Abstract] [Full Text] [Related]
25. Ferroptosis-inducing agents enhance TRAIL-induced apoptosis through upregulation of death receptor 5. Lee YS, Lee DH, Jeong SY, Park SH, Oh SC, Park YS, Yu J, Choudry HA, Bartlett DL, Lee YJ. J Cell Biochem; 2019 Jan 14; 120(1):928-939. PubMed ID: 30160785 [Abstract] [Full Text] [Related]
26. Casticin potentiates TRAIL-induced apoptosis of gastric cancer cells through endoplasmic reticulum stress. Zhou Y, Tian L, Long L, Quan M, Liu F, Cao J. PLoS One; 2013 Jan 14; 8(3):e58855. PubMed ID: 23536831 [Abstract] [Full Text] [Related]
27. Role of activating transcription factor 3 (ATF3) in endoplasmic reticulum (ER) stress-induced sensitization of p53-deficient human colon cancer cells to tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis through up-regulation of death receptor 5 (DR5) by zerumbone and celecoxib. Edagawa M, Kawauchi J, Hirata M, Goshima H, Inoue M, Okamoto T, Murakami A, Maehara Y, Kitajima S. J Biol Chem; 2014 Aug 01; 289(31):21544-61. PubMed ID: 24939851 [Abstract] [Full Text] [Related]
33. Snake venom toxin from Vipera lebetina turanica sensitizes cancer cells to TRAIL through ROS- and JNK-mediated upregulation of death receptors and downregulation of survival proteins. Park MH, Jo M, Won D, Song HS, Song MJ, Hong JT. Apoptosis; 2012 Dec 19; 17(12):1316-26. PubMed ID: 23007278 [Abstract] [Full Text] [Related]
34. Isoobtusilactone A sensitizes human hepatoma Hep G2 cells to TRAIL-induced apoptosis via ROS and CHOP-mediated up-regulation of DR5. Chen CY, Yiin SJ, Hsu JL, Wang WC, Lin SC, Chern CL. J Agric Food Chem; 2012 Apr 04; 60(13):3533-9. PubMed ID: 22400995 [Abstract] [Full Text] [Related]
35. Caudatin potentiates the anti-tumor effects of TRAIL against human breast cancer by upregulating DR5. Fei HR, Yuan C, Wang GL, Zhao Y, Li ZJ, Du X, Wang FZ. Phytomedicine; 2019 Sep 04; 62():152950. PubMed ID: 31102888 [Abstract] [Full Text] [Related]
36. Amiodarone sensitizes human glioma cells but not astrocytes to TRAIL-induced apoptosis via CHOP-mediated DR5 upregulation. Kim IY, Kang YJ, Yoon MJ, Kim EH, Kim SU, Kwon TK, Kim IA, Choi KS. Neuro Oncol; 2011 Mar 04; 13(3):267-79. PubMed ID: 21292685 [Abstract] [Full Text] [Related]
39. Cyproterone acetate enhances TRAIL-induced androgen-independent prostate cancer cell apoptosis via up-regulation of death receptor 5. Chen L, Wolff DW, Xie Y, Lin MF, Tu Y. BMC Cancer; 2017 Mar 07; 17(1):179. PubMed ID: 28270124 [Abstract] [Full Text] [Related]
40. Indomethacin sensitizes TRAIL-resistant melanoma cells to TRAIL-induced apoptosis through ROS-mediated upregulation of death receptor 5 and downregulation of survivin. Tse AK, Cao HH, Cheng CY, Kwan HY, Yu H, Fong WF, Yu ZL. J Invest Dermatol; 2014 May 07; 134(5):1397-1407. PubMed ID: 24213373 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]